MedComm,
Journal Year:
2024,
Volume and Issue:
5(4)
Published: March 23, 2024
Abstract
Since
cyclic
guanosine
monophosphate‐adenosine
monophosphate
synthase
(cGAS)–stimulator
of
interferon
genes
(STING)
signaling
pathway
was
discovered
in
2013,
great
progress
has
been
made
to
elucidate
the
origin,
function,
and
regulating
mechanism
cGAS–STING
past
decade.
Meanwhile,
triggering
transduction
mechanisms
have
continuously
illuminated.
plays
a
key
role
human
diseases,
particularly
DNA‐triggered
inflammatory
making
it
potentially
effective
therapeutic
target
for
inflammation‐related
diseases.
Here,
we
aim
summarize
ancient
origin
defense
mechanism,
as
well
triggers,
transduction,
cGAS–STING.
We
will
also
focus
on
important
roles
signal
under
pathological
conditions,
such
infections,
cancers,
autoimmune
neurological
visceral
inflammations,
review
drug
development
targeting
pathway.
The
main
directions
potential
obstacles
research
diseases
cancers
be
discussed.
These
advancements
expand
our
understanding
cGAS–STING,
provide
theoretical
basis
further
exploration
open
up
new
strategies
promising
intervention
multiple
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: Aug. 28, 2022
Abstract
Obesity
is
a
complex,
chronic
disease
and
global
public
health
challenge.
Characterized
by
excessive
fat
accumulation
in
the
body,
obesity
sharply
increases
risk
of
several
diseases,
such
as
type
2
diabetes,
cardiovascular
disease,
nonalcoholic
fatty
liver
linked
to
lower
life
expectancy.
Although
lifestyle
intervention
(diet
exercise)
has
remarkable
effects
on
weight
management,
achieving
long-term
success
at
loss
extremely
challenging,
prevalence
continues
rise
worldwide.
Over
past
decades,
pathophysiology
been
extensively
investigated,
an
increasing
number
signal
transduction
pathways
have
implicated
obesity,
making
it
possible
fight
more
effective
precise
way.
In
this
review,
we
summarize
recent
advances
pathogenesis
from
both
experimental
clinical
studies,
focusing
signaling
their
roles
regulation
food
intake,
glucose
homeostasis,
adipogenesis,
thermogenesis,
inflammation.
We
also
discuss
current
anti-obesity
drugs,
well
compounds
trials,
that
target
these
signals.
The
evolving
knowledge
may
shed
light
future
direction
research,
move
into
new
era
precision
medicine.
Journal of Medical Virology,
Journal Year:
2021,
Volume and Issue:
93(9), P. 5376 - 5389
Published: April 29, 2021
Abstract
The
suppression
of
types
I
and
III
interferon
(IFN)
responses
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2)
contributes
to
the
pathogenesis
disease
2019
(COVID‐19).
strategy
used
SARS‐CoV‐2
evade
antiviral
immunity
needs
further
investigation.
Here,
we
reported
that
ORF9b
inhibited
IFN
production
targeting
multiple
molecules
innate
signaling
pathways.
impaired
induction
IFNs
Sendai
virus
poly
(I:C).
activation
induced
components
cytosolic
dsRNA‐sensing
pathways
RIG‐I/MDA5‐MAVS
signaling,
including
RIG‐I,
MDA‐5,
MAVS,
TBK1,
IKKε,
rather
than
IRF3‐5D,
which
is
active
form
IRF3.
also
suppressed
TRIF
STING,
are
adaptor
protein
endosome
RNA‐sensing
pathway
TLR3‐TRIF
DNA‐sensing
cGAS–STING
respectively.
A
mechanistic
analysis
revealed
interacted
with
TRIF,
TBK1
impeded
phosphorylation
nuclear
translocation
In
addition,
facilitated
replication
vesicular
stomatitis
virus.
Therefore,
results
showed
negatively
regulates
thus
facilitates
viral
replication.
This
study
our
understanding
molecular
mechanism
through
impairs
provides
an
essential
clue
COVID‐19.
Molecular Cancer,
Journal Year:
2020,
Volume and Issue:
19(1)
Published: Aug. 27, 2020
Abstract
Cellular
recognition
of
microbial
DNA
is
an
evolutionarily
conserved
mechanism
by
which
the
innate
immune
system
detects
pathogens.
Cyclic
GMP-AMP
synthase
(cGAS)
and
its
downstream
effector,
stimulator
interferon
genes
(STING),
are
involved
in
mediating
fundamental
antimicrobial
immunity
promoting
release
type
I
interferons
(IFNs)
other
inflammatory
cytokines.
Accumulating
evidence
suggests
that
activation
cGAS-STING
axis
critical
for
antitumor
immunity.
The
cytokines
regulated
cGAS-STING,
especially
IFNs,
serve
as
bridges
connecting
with
adaptive
Accordingly,
a
growing
number
studies
have
focused
on
synthesis
screening
STING
pathway
agonists.
However,
chronic
may
lead
to
protumor
phenotype
certain
malignancies.
Hence,
signaling
must
be
orchestrated
properly
when
agonists
used
alone
or
combination.
In
this
review,
we
discuss
dichotomous
roles
tumor
development
latest
advances
use
Redox Biology,
Journal Year:
2022,
Volume and Issue:
52, P. 102305 - 102305
Published: March 28, 2022
Hepatocellular
cell
death
and
macrophage
proinflammatory
activation
contribute
to
the
pathology
of
various
liver
diseases,
during
which
XBP1
plays
an
important
role.
However,
function
mechanism
in
thioacetamide
(TAA)-induced
acute
injury
(ALI)
remains
unknown.
Here,
we
investigated
effects
inhibition
on
promoting
hepatocellular
pyroptosis
activate
STING
signaling
ALI.
While
both
TAA-
LPS-induced
ALI
triggered
hepatocytes,
hepatocyte-specific
knockout
mice
exhibited
exacerbated
with
increased
enhanced
activation.
Mechanistically,
mtDNA
released
from
TAA-stressed
hepatocytes
could
be
engulfed
by
macrophages,
further
inducing
a
cGAS-
dose-dependent
manner.
deficiency
ROS
production
promote
activating
NLRP3/caspase-1/GSDMD
signaling,
facilitated
extracellular
release
mtDNA.
Moreover,
impaired
mitophagy
was
found
deficient
reversed
PINK1
overexpression.
Mitophagy
restoration
also
inhibited
mice.
Activation
XBP1-mediated
pathway
were
observed
human
livers
Collectively,
these
findings
demonstrate
that
promotes
hepatocyte
impairing
mtDNA/cGAS/STING
providing
potential
therapeutic
targets
for
Cellular and Molecular Life Sciences,
Journal Year:
2022,
Volume and Issue:
79(3)
Published: March 1, 2022
Immune
checkpoint
blockade
(ICB)
therapies
have
achieved
remarkable
clinical
responses
in
patients
with
many
different
types
of
cancer;
however,
most
who
receive
ICB
monotherapy
fail
to
achieve
long-term
responses,
and
some
tumors
become
immunotherapy-resistant
even
hyperprogressive.
Type
I
interferons
(IFNs)
been
demonstrated
inhibit
tumor
growth
directly
indirectly
by
acting
upon
immune
cells,
respectively.
Furthermore,
accumulating
evidence
indicates
that
endo-
exogenously
enhancing
type
IFNs
a
synergistic
effect
on
anti-tumor
immunity.
Therefore,
trials
studying
new
treatment
strategies
combine
IFN
inducers
are
currently
progress.
Here,
we
review
the
cellular
sources
their
roles
regulation
microenvironment.
In
addition,
highlight
immunotherapies
based
combination
therapy
between
ICBs.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
34(10)
Published: Dec. 29, 2021
Radiotherapy,
a
mainstay
of
first-line
cancer
treatment,
suffers
from
its
high-dose
radiation-induced
systemic
toxicity
and
radioresistance
caused
by
the
immunosuppressive
tumor
microenvironment.
The
synergy
between
radiosensitization
immunomodulation
may
overcome
these
obstacles
for
advanced
radiotherapy.
Here,
authors
propose
cooperated
with
stimulator
interferon
genes
(STING)
pathway
activation
strategy
fabricating
novel
lanthanide-doped
radiosensitizer-based
metal-phenolic
network,
NaGdF4
:Nd@NaLuF4
@PEG-polyphenol/Mn
(DSPM).
amphiphilic
PEG-polyphenol
successfully
coordinates
(radiosensitizer)
Mn2+
via
robust
coordination.
After
cell
internalization,
pH-responsive
disassembly
DSPM
triggers
release
their
payloads,
wherein
radiosensitizer
sensitizes
cells
to
X-ray
promote
STING
activation.
This
remarkably
benefits
dendritic
maturation,
anticancer
therapeutics
in
primary
tumors,
accompanied
immune
therapeutic
performance
against
metastatic
tumors.
Therefore,
powerful
mediated
immunostimulation
is
highlighted
here
optimize
Science Immunology,
Journal Year:
2021,
Volume and Issue:
6(59)
Published: May 18, 2021
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
caused
a
global
pandemic,
resulting
millions
of
infections
and
deaths
with
few
effective
interventions
available.
Here,
we
demonstrate
that
SARS-CoV-2
evades
interferon
(IFN)
activation
in
epithelial
cells,
delayed
response
bystander
cells.
Since
pretreatment
IFNs
can
block
viral
infection,
reasoned
pharmacological
innate
immune
pathways
could
control
infection.
To
identify
potent
antiviral
agonists,
screened
panel
75
microbial
ligands
activate
diverse
signaling
identified
cyclic
dinucleotides
(CDNs),
canonical
STING
as
antiviral.
CDNs
have
poor
bioavailability,
tested
the
small
molecule
agonist
diABZI,
found
it
potently
inhibits
infection
strains
including
variants
concern
(B.1.351)
by
transiently
stimulating
IFN
signaling.
Importantly,
diABZI
restricts
replication
primary
human
bronchial
cells
mice
vivo.
Our
study
provides
evidence
may
represent
promising
therapeutic
strategy
to
SARS-CoV-2.